This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Albupharm Heidelberg Gmbh & Co. Kg. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Marcel Mülbaier: Innovator in Gyrase Inhibitor-Protein Conjugates
Introduction
Marcel Mülbaier is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of innovative methods for producing albumin conjugates containing gyrase inhibitors. His work is aimed at addressing inflammatory conditions and tumors, showcasing the potential of his inventions in medical applications.
Latest Patents
Marcel Mülbaier holds 1 patent for his invention titled "Method for producing albumin conjugates containing gyrase inhibitors." This patent focuses on a gyrase inhibitor-protein conjugate, specifically a gyrase inhibitor-albumin conjugate. The invention also outlines methods for treating inflammatory conditions and tumors, as well as the processes for creating these conjugates.
Career Highlights
Mülbaier is associated with Albupharm Heidelberg GmbH & Co. KG, where he continues to advance his research and development efforts. His work at this company has allowed him to collaborate with other experts in the field, further enhancing the impact of his inventions.
Collaborations
One of his notable coworkers is Hannsjörg Sinn, with whom he has likely shared insights and expertise in their respective areas of research.
Conclusion
Marcel Mülbaier's innovative work in the field of gyrase inhibitors and protein conjugates represents a significant advancement in medical science. His contributions have the potential to lead to new treatments for serious health conditions, underscoring the importance of his research and inventions.